Leading Corporate Venture Capital Arms for HealthTech Innovators

A leading platform connecting entrepreneurs with the resources of one of the world's largest healthcare companies. JLABS provides laboratory space, funding opportunities, and mentorship, fostering innovation in therapeutics, medtech, and digital health through its global network.

The private equity and venture capital arm of the Novo Nordisk Foundation, focusing heavily on global health and biotech investments. They provide patient capital and strategic support to companies developing cures and treatments, leveraging deep industry knowledge across the value chain.

The venture investment arm of Merck KGaA, focusing on digital health, diagnostics, and oncology innovations. They seek to identify and accelerate promising startups that can complement Merck’s core pipeline, offering access to their extensive global R&D and commercialization infrastructure.

Focused on investing in transformative technologies that address significant unmet medical needs in immunology, oncology, and cardiovascular disease. Amgen Ventures provides strategic guidance and operational support, helping startups navigate the complex regulatory and commercial landscapes of healthcare.

The investment division of Sanofi, targeting early-stage biotech and digital health companies in areas like rare diseases, immunology, and vaccines. They offer deep scientific expertise and strategic partnerships, helping innovative companies translate scientific breakthroughs into patient therapies.

Part of the Roche Group, this fund invests in innovative technologies across diagnostics and therapeutics. It supports startups by providing access to Roche’s global network, regulatory expertise, and commercialization capabilities, focusing on digital health, oncology, and neuroscience.

Strategic investments in external innovations that align with Pfizer’s therapeutic areas, including oncology, inflammation, and immunology. Pfizer Ventures helps startups scale by offering access to clinical development resources, regulatory insights, and potential commercialization pathways within a global pharmaceutical leader.

Focused on identifying and supporting transformative innovations in diabetes, obesity, oncology, and neuroscience. The fund provides strategic capital and partnership opportunities, leveraging Lilly’s extensive experience in drug development and commercialization to bring new therapies to patients faster.

A specialized investment platform within Roche that focuses on deep tech and digital health solutions. It invests in companies developing AI-driven diagnostics, digital therapeutics, and connected health devices, aiming to integrate these innovations into Roche’s broader healthcare ecosystem.

Invests in emerging biotech and digital health companies that align with AstraZeneca’s focus on oncology, cardiovascular, and respiratory diseases. They provide strategic value through access to clinical trial networks, regulatory expertise, and global commercialization support for innovative healthtech solutions.

Focused on investing in innovative companies developing treatments for infectious diseases, oncology, and inflammation. Gilead Ventures offers strategic partnerships and access to its scientific and commercial infrastructure, helping startups accelerate the development and deployment of new therapeutic approaches.

While primarily an operating company, its investment arm often partners with biotechs in rare diseases and neurology. It leverages Roche’s global reach and scientific expertise to support startups in navigating clinical development and bringing novel therapies to market efficiently.

A dedicated healthtech investment firm that bridges the gap between life sciences and technology. Vida provides capital, strategic guidance, and access to a vast network of industry experts, focusing on digital health, biotech, and healthcare services startups poised for rapid growth.

A healthtech accelerator and investment firm that helps startups scale through its proprietary platform and network. Launch provides capital, mentorship, and connections to key healthcare providers and payers, accelerating the commercialization of digital health innovations and medical devices.

A venture capital firm focused on healthcare IT, digital health, and data-driven solutions. F-Prime invests in companies leveraging technology to improve healthcare outcomes and reduce costs, offering strategic support and access to its extensive network of healthcare leaders and innovators.

A venture firm specializing in early-stage digital health and health tech startups. Red Cloud provides seed and Series A investments, along with hands-on support in product development, regulatory strategy, and go-to-market planning, helping founders build scalable healthcare businesses.

An investment firm focused on early-stage healthtech startups with a strong emphasis on digital therapeutics and AI. HealthX Ventures offers capital and strategic guidance, helping companies navigate the unique challenges of healthcare regulation, reimbursement, and clinical validation.

Part of the Crossover Health ecosystem, this investment arm focuses on integrated care delivery models and healthtech platforms. It supports innovations that improve patient outcomes while reducing costs, leveraging Crossover’s network of clinics and employers to scale successful healthtech solutions.

The corporate venture arm of Teladoc Health, investing in digital health companies that complement its telehealth platform. It seeks innovations in remote patient monitoring, mental health, and chronic care management, providing portfolio companies with access to Teladoc’s vast user base and technology stack.

Focused on investing in genomics and diagnostics companies that align with Veracyte’s mission to improve patient care. It offers strategic partnerships and access to Veracyte’s expertise in molecular diagnostics, helping startups develop and commercialize innovative genomic tests and technologies.